Peterborough City Hospital is an acute teaching hospital on the Edith Cavell Healthcare Campus serving the city of Peterborough, north Cambridgeshire, areas of east Northamptonshire and Rutland. It is managed by North West Anglia NHS Foundation Trust.

There are 612 beds in Peterborough City Hospital.

During the past decade, Peterborough City Hospital conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 8 clinical trials were completed, i.e. on average, 38.1% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 6 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Peterborough City Hospital" #1 sponsor was "Hoffmann-La Roche" with 5 trials, followed by "Peterborough and Stamford Hospitals NHS Foundation Trust" with 2 trials sponsored, "University of Oxford" with 2 trials sponsored, "Australian and New Zealand Intensive Care Research Centre" with 1 trials sponsored and "Boehringer Ingelheim" with 1 trials sponsored. Other sponsors include 19 different institutions and companies that sponsored additional 29 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Peterborough City Hospital" #1 collaborator was "Cancer Research UK" with 3 trials as a collaborator, "AstraZeneca" with 2 trials as a collaborator, "Celgene" with 2 trials as a collaborator, "National Institute for Health Research, United Kingdom" with 2 trials as a collaborator and "Academy of Finland" with 1 trials as a collaborator. Other collaborators include 42 different institutions and companies that were collaborators in the rest 52 trials.

According to Clinical.Site data, the most researched conditions in "Peterborough City Hospital" are "Breast Cancer" (5 trials), "Atrial Fibrillation" (2 trials), "Fallopian Tube Cancer" (2 trials), "Hip Fractures" (2 trials) and "Metastatic Breast Cancer" (2 trials). Many other conditions were trialed in "Peterborough City Hospital" in a lesser frequency.

Most popular intervention types in "Peterborough City Hospital" are "Drug" (21 trials), "Procedure" (5 trials), "Other" (4 trials), "Device" (3 trials) and "Radiation" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Docetaxel" (4 trials), "Paclitaxel" (4 trials), "Cyclophosphamide" (2 trials) and "Trastuzumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Peterborough City Hospital" are 30 trials for "All" genders and 5 trials for "Female" genders.

Currently, there are NaN active trials in "Peterborough City Hospital". undefined are not yet recruiting, 6 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Peterborough City Hospital, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Peterborough City Hospital, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 8 trials that are defined as “Not Applicable".